In summary, our study proves that MKLN1-AS is an oncogenic lncRNA that promotes HCC cells migration, invasion, and proliferation and can be exploited as a potential therapeutic target for HCC treatment. This evidence concerns the gene MKLN1 and hepatocellular carcinoma.